Prognostic study reveals that combining HRCT and lung function tests stratifies risk in systemic sclerosis-related lung disease, indicating clear prognostic guidance.
An easily applicable limited/extensive staging system for SSc-ILD, based on combined evaluation with HRCT and PFTs, provides discriminatory prognostic information.
No takes yet. Share an insight, caveat, or question.
Goh et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: